Tetrakis(dimethylamido)zirconium(IV)

Hazard statements (CLP)

H228, H261, H315, H319, H335

Code

Statements

H228

Flammable solid

SECTION 2: Hazards identification

2.1 Classification of the substance or mixture

Flammable solids, (Category 1) H228: Flammable solid. Substances and mixtures, which H261: In contact with water releases in contact with water, emit flammable gases. flammable gases, (Category 2) Skin irritation, (Category 2) H315: Causes skin irritation. Eye irritation, (Category 2) H319: Causes serious eye irritation. Specific target organ toxicity - H335: May cause respiratory irritation. single exposure, (Category 3),

Signal word

Danger Danger

Hazard statements

H228 Flammable solid. H261 In contact with water releases flammable gases. H315 Causes skin irritation. H319 Causes serious eye irritation. H335 May cause respiratory irritation. none

Precautionary statements

P210 Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P223 Do not allow contact with water. P231 + P232 Handle and store contents under inert gas. Protect from moisture. P240 Ground and bond container and receiving equipment. P302 + P352 IF ON SKIN: Wash with plenty of water. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. none

Supplemental label elements

EUH014 Reacts violently with water. Reduced Labelling (<= 125 ml) EUH014 Reacts violently with water.

Other hazards

This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher

ECOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.

TOXICOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.